Menu

CTI BioPharma Corp. CTIC

Full chart Compare
Set alert

Price alert · CTIC

All alert types
9.10 0.00 (+0.00%)

Jun 23, 2023, 3:58 PM EDT

9.09 Day range 9.10

52-week range unavailable

Revenue & Expenses

Income Tax Benefit → Expenses: $1.95MExpenses → Selling, General & Admin: $84.83MExpenses → Research & Development: $36.90MExpenses → Other Operating Expenses: $8.51MExpenses → Interest Expense: $13.14MExpenses → Other Expenses: $56.00KGross Profit → Expenses: $50.43MRevenue → Gross Profit: $50.43MRevenue → Cost of Revenue: $3.51MNet Loss → Expenses: $91.04MIncome Tax Benefit$1.95MGross Profit$50.43MNet Loss$91.04MCost of Revenue$3.51MExpenses$143.43MSelling, General & Admin$84.83MResearch & Development$36.90MOther Operating Expenses$8.51MInterest Expense$13.14MOther Expenses$56.00KRevenue$53.95M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

CTIC annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
53.95M003.35M26.29M
53.95M003.35M26.29M
3.51M0000
50.43M003.35M26.29M
130.23M95.33M47.77M44.06M59.19M
36.90M39.14M25.94M24.11M36.47M
84.83M56.20M17.63M19.16M22.06M
-79.80M-95.33M-47.77M-40.71M-32.90M
13.14M2.42M828.00K1.00M1.21M
-92.99M-97.91M-52.45M-40.02M-29.32M
-92.99M-97.91M-52.45M-40.02M-29.40M
-92.99M-97.91M-52.45M-40.02M-29.40M
-92.99M-97.91M-52.45M-40.02M-29.35M
-0.81-1.09-0.74-0.69-0.52
-0.81-1.09-0.74-0.69-0.52
-0.81-1.09-0.74-0.69-0.52
-79.85M-95.49M-51.62M-39.02M-28.11M
-79.85M-95.49M-51.62M-39.02M-28.11M
114.69M90.12M71.14M57.97M56.07M
114.69M90.12M71.14M57.97M56.07M